Pfizer is trying to scare us off. I am laughing at this "14c if it is not validated". They have forgotten about (or conveniently not to mention) so many things. To name a few here:
1) Quarterly revenue report is coming. If it is up another 44% and is over $250k, many people will hold firm
2) I am sure that Pfizer has been dealing with us for more than 3 months. It will be unimaginable that it has not try validating our app one way or another. So the chance is quite low for the validation to fail
3) If the validation succeeds, that means FDA, so no one will sell
4) Most important. The time is on our side. Pfizer needs to buy us and then prepare/lodge for FDA and get approved BEFORE the winter season in USA. The time line is very tight. they need to close the deal asap. When it comes to winter, they need a tool which can differentiate flu from COVID. Our tool will be the perfect fit.
So guys, please hold tight. The game is not over, it is finally on. BTW, a big NO from us.
- Forums
- ASX - By Stock
- RAP
- Ann: Increased Scheme Consideration from Pfizer
Ann: Increased Scheme Consideration from Pfizer, page-113
-
- There are more pages in this discussion • 265 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online